Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

  • Post published:March 30, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

  • Post published:March 2, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

  • Post published:February 4, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Psyched Wellness Upsizes Previously Announced Bought Deal Offering

  • Post published:January 25, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

  • Post published:January 21, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Announces New OTCQB Ticker: PSYCF

Psyched Wellness Announces New OTCQB Ticker: PSYCF

  • Post published:January 19, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

  • Post published:January 14, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

  • Post published:January 6, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

  • Post published:December 28, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More